RK, P., I, B., WT, C., DF, S., D, F., MP, K., . . . GY, L. (2021). The significance of histological activity measurements in immune checkpoint inhibitor colitis. Alimentary pharmacology & therapeutics, 53(1), 150. https://doi.org/10.1111/apt.16142
Chicago Style (17th ed.) CitationRK, Pai, et al. "The Significance of Histological Activity Measurements in Immune Checkpoint Inhibitor Colitis." Alimentary Pharmacology & Therapeutics 53, no. 1 (2021): 150. https://doi.org/10.1111/apt.16142.
MLA (9th ed.) CitationRK, Pai, et al. "The Significance of Histological Activity Measurements in Immune Checkpoint Inhibitor Colitis." Alimentary Pharmacology & Therapeutics, vol. 53, no. 1, 2021, p. 150, https://doi.org/10.1111/apt.16142.
Warning: These citations may not always be 100% accurate.